These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 109892)

  • 61. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Picomolar concentrations of L-dopa stereoselectively potentiate activities of presynaptic beta-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices.
    Goshima Y; Nakamura S; Ohno K; Misu Y
    Neurosci Lett; 1991 Aug; 129(2):214-6. PubMed ID: 1660577
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antagonism of ethanol's central stimulation by catecholamine receptor agonists.
    Svensson TH; Engberg G
    Adv Exp Med Biol; 1980; 126():535-50. PubMed ID: 6773308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [L-DOPA uptake and catecholamine synthesis in the brains of rats with altered adrenocortical hormone levels].
    Shaliapina VG; Milusheva TsB
    Probl Endokrinol (Mosk); 1977; 23(4):94-9. PubMed ID: 905266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brain catecholamine concentration during the first week of development in rats.
    Phelps CP; Korányi L; Tamásy V
    Dev Neurosci; 1982; 5(5-6):503-7. PubMed ID: 7160315
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of catecholaminergic drugs on systems of reward and punishment in experiments on cats.
    Patkina NA; Lapin IP
    Pharmacol Biochem Behav; 1976 Sep; 5(3):247-52. PubMed ID: 996056
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Catecholamine synthesis regulation in hypothalamic synaptosomes.
    Haycock DA; Patrick RL
    Brain Res; 1981 Jun; 214(2):371-85. PubMed ID: 6263421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nicotine's attenuation of body weight involves the perifornical hypothalamus.
    Kramer PR; Guan G; Wellman PJ; Bellinger LL
    Life Sci; 2007 Jul; 81(6):500-8. PubMed ID: 17655879
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tropolone antagonism of the L-dopa-induced elevation of S-adenosylhomocysteine: S-adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Leucke SK
    J Pharm Pharmacol; 1984 Jun; 36(6):419-20. PubMed ID: 6146682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding.
    Sotak BN; Hnasko TS; Robinson S; Kremer EJ; Palmiter RD
    Brain Res; 2005 Nov; 1061(2):88-96. PubMed ID: 16226228
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats.
    Li AJ; Wang Q; Elsarelli MM; Brown RL; Ritter S
    Endocrinology; 2015 Aug; 156(8):2807-20. PubMed ID: 25978516
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition by L-3,4-dihydroxyphenylalanine of hippocampal CA1 neurons with facilitation of noradrenaline and gamma-aminobutyric acid release.
    Akbar M; Ishihara K; Sasa M; Misu Y
    Eur J Pharmacol; 2001 Mar; 414(2-3):197-203. PubMed ID: 11239919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.
    De Deurwaerdère P; Di Giovanni G; Millan MJ
    Prog Neurobiol; 2017 Apr; 151():57-100. PubMed ID: 27389773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of amphetamine on catecholamine levels and turnover in discrete hypothalamic areas.
    Leibowitz SF; Jhanwar-Uniyal M; Levin BE
    Brain Res; 1983 May; 266(2):348-54. PubMed ID: 6871670
    [No Abstract]   [Full Text] [Related]  

  • 79. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
    Jeon MY; Lee WY; Kang HY; Chung EJ
    Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.